Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Artificial Intelligence Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Trials, Data, Diversity – H1’s Top 5 Diagnoses (Predictions) for Biotech and Pharma in 2024
How will AI impact clinical trials? Will FDA legislation improve diversity? What platforms will key opinion leaders adopt? Every year, we take a look at annual predictions to help life… Continue reading →

Read the article
no
Artificial Intelligence Commercialization Drug Development
Six Possible Implications of Biden’s Executive Order on AI for Life Sciences
The life sciences sector stands on the brink of a new era marked by the confluence of artificial intelligence (AI) and biomedicine. With President Biden’s recent Executive Order on AI,… Continue reading →

Read the article
no
Artificial Intelligence Commercialization Diversity & Inclusion Drug Development
7 Ways of Generating AI-produced ROI for Life Sciences
For life sciences companies, the application of AI has the potential to provide transformative value, not only in terms of direct financial return but also through operational, research, and clinical… Continue reading →

Read the article
no
Commercialization Drug Development
What Payer Trends Can Tell Us About Medication Adherence
One of the most important aspects of monitoring payer trends is getting an accurate picture of patient utilization. Understanding which treatments are being utilized, by whom, and for what… Continue reading →

Read the article
no
Commercialization
Unlocking Value-Based Care: How Pharma & MedTech Companies Can Thrive in a New Age of Private Payers and Population Health
As the healthcare industry shifts to value-based care, private payers and population health are taking the lead in determining patient care. For pharma and med tech companies, this shift… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Honored with a Spot on Y Combinator’s 2023 Best Companies List and Slice of Healthcare’s Inaugural Digital Health Leaders List
H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies… Continue reading →

Read the article
no
Commercialization KOL Engagement
Medical Public Awareness Campaigns—Examples and Effectiveness
Medical public awareness campaigns are designed to distribute important healthcare messages to large populations. With over seven billion people in the world, it is necessary to find ways to share… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
New Look, Same Commitment!
I’m excited to officially unveil the new branding and website our team has been working on for several months. This new branding comes with much thought and consideration, and reflects… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Timmy Awards Announces H1 as 2022 Tech for Good Finalist
The 8th Annual Timmy Awards run by Tech in Motion celebrates leaders in tech, recognizing the top workplaces for tech professionals across North America. We are thrilled to announce that H1 is… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
The Evolution of H1’s Core Values
I remember it clearly. Me, Ian – our co-founder and a handful of brave individuals who would become the first H1 employees, sitting around a table writing down the values… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Recognized as One of Forbes’ Best Startup Employers 2022
H1, which provides the largest global healthcare professional data ecosystem to enable life sciences, academic medical institutions, health systems, and payers, today announced it has been included on Forbes’… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Named to NYC Digital Health 100 by NYCHBL
H1, which provides the largest global healthcare platform that connects healthcare professionals, today announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Wraps Up 2021 with Gratitude
2021 was a year of enormous change around the world, as we learn to live and work in new ways. For H1, it was also a year of enormous growth,… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Co-Founder and CEO of H1 Named to Forbes 30 Under 30
H1 announced today that its CEO and Co-Founder Ariel Katz was named to the prestigious Forbes 30 under 30 list. Ariel started his first company in college, ResearchConnection, to help… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Ziad Ismail Joins H1 During Period of High Growth
H1, which provides the largest global healthcare network that connects healthcare professionals, announced today that it has added Ziad Ismail to the management team as Chief Operating Officer. Ziad… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Raises Series C
Today we announced our Series C of $100 million led by Altimeter and participation from new investors including Goldman Sachs Asset Management and Flex Capital. It also includes the support… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Former Dropbox CIO Joins Board of Healthcare Data Startup H1
Board member Sylvie Veilleux (Salesforce, Dropbox), CFO Karen Moran (Alteryx, Domo) and CDO Mayur Thakur (Goldman Sachs, Google) bring decades of experience and add bench strength as H1 expands.… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development
Why Diversity Matters for Pharma
Diversity matters for pharma because inclusion, trust and equity matter for pharma. When developing therapies and medications, pharmaceutical and life sciences companies are tasked with designing products for a… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Closes $58 Million Series B Funding
Today, H1 announced a $58 million Series B round of funding to continue working towards our mission of creating a healthier future by connecting parties in the healthcare ecosystem.… Continue reading →

Read the article
Commercialization
Medical Nanotechnology: What’s Real & What’s Not
Since Elon Musk’s tweet characterizing nanotech as “BS,” there’s been a continuing debate about the practical applications of nanotechnology — and where the dividing line between innovation and hype lies. Medical nanotechnology,… Continue reading →

Read the article
Commercialization
Medicare for All: Pros & Cons
Healthcare is one of the hottest topics as presidential hopefuls gear up for the next election. Candidates vying for the Democratic nomination have introduced or thrown their support behind one… Continue reading →

Read the article
Commercialization
Hospital Procurement: What You Need To Know
Last July, we published a blog on Mapping the Medical Sales Cycle, and a key part of the medical sales process includes understanding the steps involved in hospital procurement. The end… Continue reading →

Read the article
Commercialization
The Top Selling Medical Devices of 2018
New to medical device sales and don’t know who the key players are? We’ve got you covered. The top selling medical devices and their parent companies in 2018 covered 40%… Continue reading →

Read the article
Commercialization
The Challenges of Unstructured Healthcare Data
During every patient encounter healthcare providers rely on hundreds of discrete data signals on which they base their decisions in order to provide effective treatment. As care teams assess, diagnose… Continue reading →

Read the article
Commercialization
What’s the Outlook for Medical Device Mergers & Acquisitions?
The medical device industry experienced significant M&A in 2018. High-value deals included Boston Scientific’s $4 billion buyout of BTG (expected to close in a few months), Medtronic’s acquisition of Mazor Robotics for $1.64… Continue reading →

Read the article
Commercialization
Networking Tips for Medical Conferences
Medical conferences often bring together a variety of stakeholders with the unique opportunity to share insights and discuss what’s happening in the industry. As a sales or marketing professional, you’ve… Continue reading →

Read the article
Commercialization
Healthcare Cloud Adoption & How It Can Impact Medtech Sales
After a slow start, cloud computing in the medical field is seeing a higher rate of adoption. MarketsandMarkets projects the global healthcare cloud computing market, with North America leading the… Continue reading →

Read the article
Commercialization
How to Estimate Market Opportunity When Launching New MedTech Products
Imagine your team has been iterating on an innovative idea for a new MedTech device. So how do you decide if commercializing that product will result in ROI for your… Continue reading →

Read the article
Commercialization
The Dos & Don’ts of Healthcare Datasets
Where will you find your next MedTech sales opportunity? Healthcare datasets can be great tools for identifying prime prospects in your market. Leveraging healthcare datasets to market your MedTech systems,… Continue reading →

Read the article
Commercialization
Sales Associations & Networking Groups for MedTech Professionals
MedTech salespeople are understandably so focused on their day-to-day sales activities and quotas that they often miss opportunities to improve their knowledge, skills, and networking opportunities. The most proactive MedTech… Continue reading →

Read the article
Commercialization
9 Tips To Improve Email Marketing to Physicians
Any discussion of email marketing to physicians must begin with the understanding that most doctors are incredibly busy. Some are so busy they barely have enough time to provide proper… Continue reading →

Read the article